Volume 38 • Number 11NOVEMBER 2008
Challenges in Comorbidity
The aim of this issue of Psychiatric Annals is to convey state-of-the-art information about diagnosing and treating anxiety, bipolar, and depressive disorders and suicide risk in patients with comorbid substance use disorders, presented by recognized experts in each of these domains.
Editorial
The Role of Comorbidity in Severity and Outcome
Jan Fawcett, MD
From the Guest Editor
Challenges in Comorbidity
Barbara J. Mason, PhD
Psychiatry in the News
Clinical Implications of Epidemiologic Data for Diagnosis and Treatment of Psychiatric ComorbiditySharon Samet, PhD; Deborah Hasin, PhD
Diagnostic and Treatment Considerations: Bipolar Patients with Comorbid Substance Use DisordersIhsan Salloum, MD, MPH; Antoine Douaihy, MD; Lauren Williams, MD
Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment ConsiderationsSudie E. Back, PhD; Kathleen T. Brady, MD, PhD
Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical RecommendationsEdward V. Nunes, MD; Frances R. Levin, MD
Psychiatric Risk Factors for Suicide in the Alcohol-dependent Patient
Kenneth R. Conner, PsyD, MPH; Michael S. McCloskey, PhD; Paul R. Duberstein, PhD
See these other publications from SLACK Incorporated
